ADA Scientific Sessions 2025 Abstract

Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)

By David N. O'Neal, Adrian Sartoretto, Sujievvan Chandran, Elif Ilhan Ekinci

Trial in peopleInterventions

The paper

David N. O'Neal, Adrian Sartoretto, Sujievvan Chandran, Elif Ilhan Ekinci

Fitzroy

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 880-P

doi.org/10.2337/db25-880-p

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety